Results 151 to 160 of about 4,953 (173)

Extramedullary disease in Waldenström macroglobulinemia: A population-based observational study. [PDF]

EJHaem
Østergaard S, Munksgaard L, Nielsen TH, Hammer T, Pedersen LM, Ølgod Pedersen M, Gjerdrum LMR.   +6 more
europepmc   +1 more source

Correction to "Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia". [PDF]

Hemasphere
europepmc   +1 more source

Two Cases of Prurigo Nodularis in Hematologic Malignancies: Hodgkin Lymphoma and Waldenström Macroglobulinemia. [PDF]

Cureus
Reis F, Sarmento F, Sarmento S, Freixa M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Differential Diagnosis of Waldenström’s Macroglobulinemia and Early Management: Perspectives from Clinical Practice

Blood and Lymphatic Cancer: Targets and Therapy, 2022
Shashank Cingam, Surbhi Sidana
exaly  

Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis

Seminars in Hematology, 2023
Giampaolo Merlini
exaly  

Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia

Seminars in Hematology, 2023
Merav Leiba, Ramon Garcia-Sanz
exaly  

Extended rituximab therapy in Waldenström's macroglobulinemia

Annals of Oncology, 2005
C Emmanouilides, F Preffer, Steven P Tréon   +2 more
exaly  

A new era for Waldenstrom macroglobulinemia: MYD88 L265P

Blood, 2013
Steven P Tréon, Zachary R Hunter, Tréon Steven P   +2 more
exaly  

International prognostic scoring system for Waldenström macroglobulinemia

Blood, 2009
Pierre Morel, Meletios A Dimopoulos, Enrique M Ocio   +2 more
exaly  

Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia

Annals of Oncology, 2004
D Santos, Steven P Tréon
exaly